Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nucaps Nanotechnology is a Spanish biotechnology company specializing in the development of natural nanotechnology solutions for the oral administration of bioactive compounds and probiotics. The company utilizes a proprietary platform based on natural food proteins to create nanocapsules and biocapsules that protect active ingredients from degradation and significantly enhance their bioavailability. Their technology is applied across the pharmaceutical, nutraceutical, and functional food industries to improve the delivery of vitamins, minerals, and therapeutic agents. Nucaps operates as a technology provider and research partner, offering both IP licensing and tailor-made encapsulation services to global health and nutrition companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nucap.